The maker of glucose monitoring devices said investigations of its San Diego, Calif., and Mesa, Ariz., facilities discovered ...

Dexcom has received a warning letter from the FDA, after the agency uncovered issues during two inspections of the continuous ...

Medical device companies presented new data this week at the Advanced Technologies & Treatments for Diabetes conference.

Dexcom, a medical device manufacturer that develops continuous glucose monitoring systems, received a warning letter from the FDA regarding manufacturing processes at its facilities in San Diego and ...

AI-enhanced glucose monitoring provides predictive analytics and personalized insights for better blood sugar management.

A survey conducted by the continuous glucose monitor maker Dexcom found that just over half of healthcare providers ranked technology and education as having larger impacts when it comes | Dexcom ...

He described how the system, which consists of two ... Its wearable devices, like the Dexcom G6 and G7, provide real-time glucose monitoring without finger pricks, transmitting data to smartphones ...

Over 13 weeks, adults with type 2 diabetes using an automated insulin delivery (AID) system had a 0.6-percentage point ...

Analysts at William Blair reduced their Q1 2025 earnings estimates for shares of DexCom in a research note issued to ...

The maker of glucose monitoring devices said investigations ... "non-conformities" in manufacturing and quality management system. DexCom said the letter won't impact operations and results.